[Prolonged antibiotic therapy of pulmonary tuberculosis with isoniazid combined with streptomycin or PAS; indications for pneumothorax].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents; D007536:Isomerism; D007538:Isoniazid; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011030:Pneumothorax; D011031:Pneumothorax, Artificial; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D007538:Isoniazid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; PNEUMOTHORAX, ARTIFICIAL; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
L'antibiothérapie prolongée de la tuberculose pulmonaire par l'isoniazide associé a la streptomycine ou au P.A.S. incidence sur les indications du pneumothorax.